• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD INC. (COVINGTON) -1018233 BARD® INLAY OPTIMA® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE Back to Search Results
Catalog Number 787626
Medical Device Problem Code Material Protrusion/Extrusion (2979)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/21/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that on (b)(6) 2025 during the use of the ureteral stent, after opening the packaging and removing the stent, it was discovered that the stent coating was rough and tight, making it impossible to insert into the body.The hospital contacted their company on the same day, and they provided detailed information to the company on (b)(6) 2025.
 
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Additional Manufacturer Narrative
The reported event was unconfirmed.Summary analysis: (include analysis/dissection of returned sample) sample provided was evaluated visually to confirm roughness and tightness of coating.Tubing was found free of lumps, flat spots, voids, or other deformities.Eyes were cleanly punched with no loose materials, excessive ragged edges, or plugged eyes.All printed features were present and legible.Eye location and number were conforming to drawing.The outer body of the stent tubing was found to be smooth with a gloved hand, and no roughness was found to be present.Guidewire was ran through the stent from kidney end to distal tip.Guidewire was able to pass through with no resistance.The reported event was unconfirmed.Risk, labelling, and dhr review are not required as the reported event was unconfirmed.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that on (b)(6) 2025 during the use of the ureteral stent, after opening the packaging and removing the stent, it was discovered that the stent coating was rough and tight, making it impossible to insert into the body.The hospital contacted their company on the same day, and they provided detailed information to the company on (b)(6) 2025.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BARD® INLAY OPTIMA® URETERAL STENT WITH HYDROGLIDE¿ GUIDEWIRE
Common Device Name
URETERAL STENT
Manufacturer (Section D)
C.R. BARD INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key22904280
Report Number1018233-2025-07134
Device Sequence Number18147198
Product Code FAD
UDI-Device Identifier10801741015448
UDI-Public(01)10801741015448(11)250201(17)290731(10)NGJZ2114
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K043193
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 02/26/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number787626
Device Lot NumberNGJZ2114
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/22/2025
Supplement Date Received by Manufacturer02/26/2026
Initial Report FDA Received Date08/27/2025
Supplement Report FDA Received Date03/03/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/01/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-